If a pharmacist substitutes an interchangeable biological product, which of the following is true about notifying the physician?

When a pharmacist substitutes an interchangeable biological product for a prescribed drug, they are required to notify the physician within a specified timeframe. In Ohio, the law mandates that the pharmacist must inform the prescriber no later than 7 days after the substitution has been made. This requirement ensures that the physician is aware of the change, which is important for ongoing patient care and monitoring for efficacy and side effects related to the biological product.

This notification process helps maintain the collaborative relationship between pharmacists and physicians, ensuring that patient safety and treatment outcomes remain a priority. It reflects the regulatory framework in place that supports transparency in medication management, especially for biological products that may have complex effects on patient health. Understanding this requirement is crucial for pharmacists to comply with state laws and to foster effective communication with healthcare providers.